Kiora Pharmaceuticals
Pre-clinicalKiora targets critical pathways underlying vision-threatening retinal diseases using innovative small molecules to slow, stop, or restore vision loss. We focus on conditions with limited or no effective therapies.
Founded
2015
Focus
Drug Delivery
About
Kiora targets critical pathways underlying vision-threatening retinal diseases using innovative small molecules to slow, stop, or restore vision loss. We focus on conditions with limited or no effective therapies.
Funding History
2Total raised: $35M
Series B$25MUndisclosedMar 15, 2023
Series A$10MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2015
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile